A citation-based method for searching scientific literature

Michael K O'Connor, Thuy D Tran, Tiffinee N Swanson, Lacey R Ellingson, Katie N Hunt, Dana H Whaley. EJNMMI Res 2017
Times Cited: 6







List of co-cited articles
17 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Evaluation of a Hanging-Breast PET System for Primary Tumor Visualization in Patients With Stage I-III Breast Cancer: Comparison With Standard PET/CT.
Suzana C Teixeira, José Ferrér Rebolleda, Bas B Koolen, Jelle Wesseling, Raúl Sánchez Jurado, Marcel P M Stokkel, María Del Puig Cózar Santiago, Vincent van der Noort, Emiel J Th Rutgers, Renato A Valdés Olmos. AJR Am J Roentgenol 2016
20
83

Dedicated Breast Positron Emission Tomography for the Evaluation of Early Response to Neoadjuvant Chemotherapy in Breast Cancer.
Ella F Jones, Kimberly M Ray, Wen Li, Youngho Seo, Benjamin L Franc, Amy J Chien, Laura J Esserman, Miguel H Pampaloni, Bonnie N Joe, Nola M Hylton. Clin Breast Cancer 2017
6
50

Design and evaluation of the MAMMI dedicated breast PET.
L Moliner, A J Gonzalez, A Soriano, F Sanchez, C Correcher, A Orero, M Carles, L F Vidal, J Barbera, L Caballero,[...]. Med Phys 2012
39
50

First clinical experience with a dedicated PET for hanging breast molecular imaging.
B B Koolen, T S Aukema, A J González Martínez, W V Vogel, L Caballero Ontanaya, M J Vrancken Peeters, C J J Vroonland, E J Rutgers, J M Benlloch Baviera, R A Valdés Olmos. Q J Nucl Med Mol Imaging 2013
14
33

Can positron emission mammography help to identify clinically significant breast cancer in women with suspicious calcifications on mammography?
Almir G V Bitencourt, Eduardo N P Lima, Bruna R C Macedo, Jorge L F A Conrado, Elvira F Marques, Rubens Chojniak. Eur Radiol 2017
7
33

Pathological complete response and long-term clinical benefit in breast cancer: the CTNeoBC pooled analysis.
Patricia Cortazar, Lijun Zhang, Michael Untch, Keyur Mehta, Joseph P Costantino, Norman Wolmark, Hervé Bonnefoi, David Cameron, Luca Gianni, Pinuccia Valagussa,[...]. Lancet 2014
33


PET imaging of oestrogen receptors in patients with breast cancer.
Michel van Kruchten, Elisabeth G E de Vries, Myles Brown, Erik F J de Vries, Andor W J M Glaudemans, Rudi A J O Dierckx, Carolien P Schröder, Geke A P Hospers. Lancet Oncol 2013
130
33

Dedicated breast PET value to evaluate BI-RADS 4 breast lesions.
L Graña-López, M Herranz, I Domínguez-Prado, S Argibay, A Villares, A Ruibal, M Vázquez-Caruncho. Eur J Radiol 2018
3
66

Dedicated breast PET for detecting residual disease after neoadjuvant chemotherapy in operable breast cancer: A prospective cohort study.
Shinsuke Sasada, Norio Masumoto, Noriko Goda, Keiko Kajitani, Akiko Emi, Takayuki Kadoya, Morihito Okada. Eur J Surg Oncol 2018
10
33

The Image Biomarker Standardization Initiative: Standardized Quantitative Radiomics for High-Throughput Image-based Phenotyping.
Alex Zwanenburg, Martin Vallières, Mahmoud A Abdalah, Hugo J W L Aerts, Vincent Andrearczyk, Aditya Apte, Saeed Ashrafinia, Spyridon Bakas, Roelof J Beukinga, Ronald Boellaard,[...]. Radiology 2020
665
33

Texture analysis of high-resolution dedicated breast 18 F-FDG PET images correlates with immunohistochemical factors and subtype of breast cancer.
Alexis Moscoso, Álvaro Ruibal, Inés Domínguez-Prado, Anxo Fernández-Ferreiro, Míchel Herranz, Luis Albaina, Sonia Argibay, Jesús Silva-Rodríguez, Juan Pardo-Montero, Pablo Aguiar. Eur J Nucl Med Mol Imaging 2018
22
33

3D Slicer as an image computing platform for the Quantitative Imaging Network.
Andriy Fedorov, Reinhard Beichel, Jayashree Kalpathy-Cramer, Julien Finet, Jean-Christophe Fillion-Robin, Sonia Pujol, Christian Bauer, Dominique Jennings, Fiona Fennessy, Milan Sonka,[...]. Magn Reson Imaging 2012
33

Partial-volume effect in PET tumor imaging.
Marine Soret, Stephen L Bacharach, Irène Buvat. J Nucl Med 2007
900
33

Computational Radiomics System to Decode the Radiographic Phenotype.
Joost J M van Griethuysen, Andriy Fedorov, Chintan Parmar, Ahmed Hosny, Nicole Aucoin, Vivek Narayan, Regina G H Beets-Tan, Jean-Christophe Fillion-Robin, Steve Pieper, Hugo J W L Aerts. Cancer Res 2017
33

Breast cancer: comparative effectiveness of positron emission mammography and MR imaging in presurgical planning for the ipsilateral breast.
Wendie A Berg, Kathleen S Madsen, Kathy Schilling, Marie Tartar, Etta D Pisano, Linda Hovanessian Larsen, Deepa Narayanan, Al Ozonoff, Joel P Miller, Judith E Kalinyak. Radiology 2011
100
33

18F-FDG PET uptake characterization through texture analysis: investigating the complementary nature of heterogeneity and functional tumor volume in a multi-cancer site patient cohort.
Mathieu Hatt, Mohamed Majdoub, Martin Vallières, Florent Tixier, Catherine Cheze Le Rest, David Groheux, Elif Hindié, Antoine Martineau, Olivier Pradier, Roland Hustinx,[...]. J Nucl Med 2015
277
33

Observer variability of Breast Imaging Reporting and Data System (BI-RADS) for breast ultrasound.
Hye-Jeong Lee, Eun-Kyung Kim, Min Jung Kim, Ji Hyun Youk, Ji Young Lee, Dae Ryong Kang, Ki Keun Oh. Eur J Radiol 2008
108
16

Diffusion-weighted breast MRI: Clinical applications and emerging techniques.
Savannah C Partridge, Noam Nissan, Habib Rahbar, Averi E Kitsch, Eric E Sigmund. J Magn Reson Imaging 2017
143
16

Pathologic Findings of Breast Lesions Detected on Magnetic Resonance Imaging.
Seema B Jabbar, Beverly Lynch, Stephen Seiler, Helena Hwang, Sunati Sahoo. Arch Pathol Lab Med 2017
12
16

FDG PET/CT: EANM procedure guidelines for tumour imaging: version 2.0.
Ronald Boellaard, Roberto Delgado-Bolton, Wim J G Oyen, Francesco Giammarile, Klaus Tatsch, Wolfgang Eschner, Fred J Verzijlbergen, Sally F Barrington, Lucy C Pike, Wolfgang A Weber,[...]. Eur J Nucl Med Mol Imaging 2015
16

Magnetic resonance imaging of the breast: recommendations from the EUSOMA working group.
Francesco Sardanelli, Carla Boetes, Bettina Borisch, Thomas Decker, Massimo Federico, Fiona J Gilbert, Thomas Helbich, Sylvia H Heywang-Köbrunner, Werner A Kaiser, Michael J Kerin,[...]. Eur J Cancer 2010
533
16

Correlation between PET/CT results and histological and immunohistochemical findings in breast carcinomas.
Almir Galvão Vieira Bitencourt, Eduardo Nóbrega Pereira Lima, Rubens Chojniak, Elvira Ferreira Marques, Juliana Alves de Souza, Luciana Graziano, Wesley Pereira Andrade, Cynthia Aparecida Bueno de Toledo Osório. Radiol Bras 2014
21
16

BI-RADS lexicon for US and mammography: interobserver variability and positive predictive value.
Elizabeth Lazarus, Martha B Mainiero, Barbara Schepps, Susan L Koelliker, Linda S Livingston. Radiology 2006
296
16

Breast MRI: EUSOBI recommendations for women's information.
Ritse M Mann, Corinne Balleyguier, Pascal A Baltzer, Ulrich Bick, Catherine Colin, Eleanor Cornford, Andrew Evans, Eva Fallenberg, Gabor Forrai, Michael H Fuchsjäger,[...]. Eur Radiol 2015
192
16

A molecular approach to breast imaging.
Amy M Fowler. J Nucl Med 2014
38
16

Advantages and limitations of FDG PET in the follow-up of breast cancer.
Peter Lind, Isabel Igerc, Thomas Beyer, Peter Reinprecht, Klaus Hausegger. Eur J Nucl Med Mol Imaging 2004
53
16

Apparent diffusion coefficient (ADC) value to evaluate BI-RADS 4 breast lesions: correlation with pathological findings.
Yazmín Aseret Ramírez-Galván, Servando Cardona-Huerta, Elfa Ibarra-Fombona, Guillermo Elizondo-Riojas. Clin Imaging 2015
18
16

False-positive lesions mimicking breast cancer on FDG PET and PET/CT.
Margaret Adejolu, Lei Huo, Eric Rohren, Lumarie Santiago, Wei T Yang. AJR Am J Roentgenol 2012
75
16

US of breast masses categorized as BI-RADS 3, 4, and 5: pictorial review of factors influencing clinical management.
Sughra Raza, Allison L Goldkamp, Sona A Chikarmane, Robyn L Birdwell. Radiographics 2010
47
16

Assessment of BI-RADS category 4 lesions detected with screening mammography and screening US: utility of MR imaging.
Kevin Strobel, Simone Schrading, Nienke L Hansen, Alexandra Barabasch, Christiane K Kuhl. Radiology 2015
49
16

PET Tracers for Clinical Imaging of Breast Cancer.
Iván Peñuelas, Inés Domínguez-Prado, María J García-Velloso, Josep M Martí-Climent, Macarena Rodríguez-Fraile, Carlos Caicedo, María Sánchez-Martínez, José A Richter. J Oncol 2012
13
16


Nonpalpable BI-RADS 4 breast lesions: sonographic findings and pathology correlation.
Eda Elverici, Ayşe Nurdan Barça, Hafize Aktaş, Arzu Özsoy, Betül Zengin, Mehtap Çavuşoğlu, Levent Araz. Diagn Interv Radiol 2015
23
16

Biopsy rate and positive predictive value for breast cancer in BI-RADS category 4 breast lesions.
Cholatip Wiratkapun, Weeraya Bunyapaiboonsri, Bussanee Wibulpolprasert, Panuwat Lertsithichai. J Med Assoc Thai 2010
19
16

Quantitative fluoroestradiol positron emission tomography imaging predicts response to endocrine treatment in breast cancer.
Hannah M Linden, Svetlana A Stekhova, Jeanne M Link, Julie R Gralow, Robert B Livingston, Georgiana K Ellis, Philip H Petra, Lanell M Peterson, Erin K Schubert, Lisa K Dunnwald,[...]. J Clin Oncol 2006
256
16

MRI measurements of breast tumor volume predict response to neoadjuvant chemotherapy and recurrence-free survival.
Savannah C Partridge, Jessica E Gibbs, Ying Lu, Laura J Esserman, Debasish Tripathy, Dulcy S Wolverton, Hope S Rugo, E Shelley Hwang, Cheryl A Ewing, Nola M Hylton. AJR Am J Roentgenol 2005
190
16

Insight into the heterogeneity of breast cancer through next-generation sequencing.
Hege G Russnes, Nicholas Navin, James Hicks, Anne-Lise Borresen-Dale. J Clin Invest 2011
150
16

Between-patient and within-patient (site-to-site) variability in estrogen receptor binding, measured in vivo by 18F-fluoroestradiol PET.
Brenda F Kurland, Lanell M Peterson, Jean H Lee, Hannah M Linden, Erin K Schubert, Lisa K Dunnwald, Jeanne M Link, Kenneth A Krohn, David A Mankoff. J Nucl Med 2011
46
16

A Randomized Feasibility Study of 18F-Fluoroestradiol PET to Predict Pathologic Response to Neoadjuvant Therapy in Estrogen Receptor-Rich Postmenopausal Breast Cancer.
Sun Young Chae, Sung-Bae Kim, Sei Hyun Ahn, Hye Ok Kim, Dok Hyun Yoon, Jin-Hee Ahn, Kyung Hae Jung, Sangwon Han, Seung Jun Oh, Sang Ju Lee,[...]. J Nucl Med 2017
26
16

The relation between estrogen receptors and response rate to cytotoxic chemotherapy in metastatic breast cancer.
M E Lippman, J C Allegra, E B Thompson, R Simon, A Barlock, L Green, K K Huff, H M Do, S C Aitken, R Warren. N Engl J Med 1978
307
16

Magnetic resonance in the detection of breast cancers of different histological types.
Rebecca M Mayrhofer, Hsiao Piau Ng, Thomas C Putti, Philip W Kuchel. Magn Reson Insights 2013
9
16

Is the standard uptake value (SUV) appropriate for quantification in clinical PET imaging? - Variability induced by different SUV measurements and varying reconstruction methods.
Cornelia Brendle, Jürgen Kupferschläger, Konstantin Nikolaou, Christian la Fougère, Sergios Gatidis, Christina Pfannenberg. Eur J Radiol 2015
26
16

Phase III, multicenter, double-blind, randomized study of letrozole, an aromatase inhibitor, for advanced breast cancer versus megestrol acetate.
A Buzdar, J Douma, N Davidson, R Elledge, M Morgan, R Smith, L Porter, J Nabholtz, X Xiang, C Brady. J Clin Oncol 2001
275
16

Lobular breast cancer series: imaging.
Karen Johnson, Deba Sarma, E Shelley Hwang. Breast Cancer Res 2015
52
16

Superior efficacy of letrozole versus tamoxifen as first-line therapy for postmenopausal women with advanced breast cancer: results of a phase III study of the International Letrozole Breast Cancer Group.
H Mouridsen, M Gershanovich, Y Sun, R Pérez-Carrión, C Boni, A Monnier, J Apffelstaedt, R Smith, H P Sleeboom, F Jänicke,[...]. J Clin Oncol 2001
735
16

The structural basis of estrogen receptor/coactivator recognition and the antagonism of this interaction by tamoxifen.
A K Shiau, D Barstad, P M Loria, L Cheng, P J Kushner, D A Agard, G L Greene. Cell 1998
16

The multigene signature MammaPrint impacts on multidisciplinary team decisions in ER+, HER2- early breast cancer.
R Exner, Z Bago-Horvath, R Bartsch, M Mittlboeck, V P Retèl, F Fitzal, M Rudas, C Singer, G Pfeiler, M Gnant,[...]. Br J Cancer 2014
26
16


The development of estrogen and progestin radiopharmaceuticals for imaging breast cancer.
J A Katzenellenbogen, M J Welch, F Dehdashti. Anticancer Res 1997
59
16


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.